Bioventus Competitors

BVS Stock  USD 5.20  0.04  0.78%   
Bioventus competes with Medigus, Motus GI, and Movano; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing Bioventus competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bioventus to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bioventus Correlation with its peers.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bioventus competition on your existing holdings.
  
Return On Capital Employed is likely to drop to 0.02 in 2024. Return On Assets is likely to gain to -0.18 in 2024. At this time, Bioventus' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 3.3 M in 2024, whereas Total Assets are likely to drop slightly above 788.8 M in 2024.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioventus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.695.188.67
Details
Intrinsic
Valuation
LowRealHigh
0.914.407.89
Details
Naive
Forecast
LowNextHigh
1.354.838.32
Details
3 Analysts
Consensus
LowTargetHigh
4.104.505.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bioventus. Your research has to be compared to or analyzed against Bioventus' peers to derive any actionable benefits. When done correctly, Bioventus' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bioventus.

Bioventus Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bioventus and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bioventus and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bioventus does not affect the price movement of the other competitor.
MDGS
MOTS
MOVE
MDGS
0.820.75
MDGS
MOTS
0.820.84
MOTS
MOVE
0.750.84
MOVE
MDGS
MOTS
MOVE
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Bioventus Stock performing well and Bioventus Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bioventus' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Bioventus and related stocks such as Medigus Ltd ADR, Motus GI Holdings, and Movano Inc Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
MDGS(3.3 M)(3.3 M)(3.3 M)(1.5 M)(5.8 M)(9.5 M)(9 M)(2.5 M)(6.6 M)(14.2 M)(6.8 M)M(10.2 M)(9.2 M)(9.6 M)
MOTS(6 M)(6 M)(6 M)(6 M)(6 M)(6 M)(8 M)(13.2 M)(22.3 M)(22.6 M)(19.6 M)(18.9 M)(18.1 M)(12.9 M)(13.5 M)
MOVE545 K7.3 M5.6 M574 K(8.4 M)(8.4 M)(8.4 M)(8.4 M)(8.4 M)(8.4 M)(14 M)(22.6 M)(30.2 M)(31.3 M)(29.7 M)

Bioventus and related stocks such as Medigus Ltd ADR, Motus GI Holdings, and Movano Inc Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Bioventus financial statement analysis. It represents the amount of money remaining after all of Bioventus operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Bioventus Competitive Analysis

The better you understand Bioventus competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bioventus' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bioventus' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BVSMDGSMOTSMOVE
 0.78 
 5.20 
Bioventus
 3.52 
 2.74 
Medigus
 4.76 
 0.44 
Motus
 2.50 
 0.41 
Movano
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Bioventus Competition Performance Charts

Five steps to successful analysis of Bioventus Competition

Bioventus' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bioventus in relation to its competition. Bioventus' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bioventus in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bioventus' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bioventus, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bioventus position

In addition to having Bioventus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Thematic Idea Now

Insurance
Insurance Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Insurance theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bioventus is a strong investment it is important to analyze Bioventus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bioventus' future performance. For an informed investment choice regarding Bioventus Stock, refer to the following important reports:
Check out Bioventus Correlation with its peers.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Bioventus Stock analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
8.178
Quarterly Revenue Growth
0.076
Return On Assets
0.0012
Return On Equity
(0.38)
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.